GNPX CIK: 1595248

Genprex, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−17.6
FY23:
−24.7
FY24:
−17.9
FY25:
−15.3
Change from FY21 to FY25
millions USD
FY21:
−0.08
FY22:
−0.06
FY23:
−0.07
FY24:
0.77
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
25.7
FY22:
0.01
FY23:
10.6
FY24:
12.0
FY25:
21.5
millions USD
FY21:
11.3
FY22:
−17.7
FY23:
−14.2
FY24:
−5.14
FY25:
6.23
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−17.6
FY23:
–
FY24:
–
FY25:
−15.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data